Filing Details
- Accession Number:
- 0001179110-20-012333
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-31 13:15:33
- Reporting Period:
- 2020-12-29
- Accepted Time:
- 2020-12-31 13:15:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1551152 | Abbvie Inc. | ABBV | Pharmaceutical Preparations (2834) | 320375147 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1761675 | Ryan Jeffrey Stewart | 1 North Waukegan Road North Chicago IL 60064 | Evp, Commercial Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2020-12-29 | 25,290 | $51.42 | 76,259 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2020-12-29 | 25,290 | $105.00 | 50,969 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to buy) | Acquisiton | 2020-12-29 | 25,290 | $0.00 | 25,290 | $51.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-02-20 | 2024-02-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.01 Par Value | 1,338 | Indirect | By spouse in trust |
Footnotes
- The reporting person disclaims beneficial ownership of these securities.
- Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Billionaire Hedge Funds
